BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma P, Yadav P, Jain RP, Bera AK, Karunagaran D. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Life Sci 2021;291:120268. [PMID: 34973275 DOI: 10.1016/j.lfs.2021.120268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Taverna S, Tonacci A, Ferraro M, Cammarata G, Cuttitta G, Bucchieri S, Pace E, Gangemi S. High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases. Cells 2022;11:849. [PMID: 35269471 DOI: 10.3390/cells11050849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sharma P, Yadav P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D. HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sci 2022;:120727. [PMID: 35753437 DOI: 10.1016/j.lfs.2022.120727] [Reference Citation Analysis]